Myricetin protects against doxorubicin-induced liver damage by modulating oxidative and inflammatory pathways.

BACKGROUND: Doxorubicin (Dox) is a highly effective chemotherapy drug used to treat various cancers. However, its clinical application is limited by liver toxicity, which is mainly caused by oxidative stress, inflammation, and mitochondrial damage. M…

Preview only. Read the full abstract at the source